pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 4·1 min read
save

Study finds fatherhood may lower early mortality, calls for more focus on paternal deaths

May 4, 2026·read at STAT ↗Neutral

Researchers published a letter in JAMA Pediatrics calling for greater study of paternal deaths, noting that being a father may lower early mortality.

The authors cite a pilot study from Georgia that tracked fathers of children born in a single year and recorded almost 800 deaths within the first five years of fatherhood.

They argue that, like maternal health, paternal mortality deserves focused surveillance and public health interventions.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Researchers urge study of paternal deaths, though a new paper finds fatherhood is protective”

read at STAT ↗
1,271 words · retrieved May 4
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADINGNew York UniversityNorthwestern University
drugs
MIFEPRISTONE
topics
ImmunologyMonoclonal AntibodyWomen's Health

related stories

  • May 6ASCO 2026 HR+ and HER2+ Breast Cancer Preview: Read up on the Insights to Know Before You Goonclive
  • 3d agoCaribou layoffs could wipe out 90% of staffBioSpace
  • Aug 5Amgen’s MariTide stands alone after obesity cull while analysts seek more M&ABioSpace
  • Aug 4Merck’s $10.8B Prometheus deal delivers another win—plus a Phase 2b missBioSpace
  • Jul 29AbCellera, Vertex partner on next-gen T-cell engagersBioPharma Dive